Affiliation:
1. Research Institute of Obstetrics and Pediatrics, Rostov State Medical University
Abstract
A clinical case of a familial form of peroxisomal D-bifunctional protein (DBP) deficiency (OMIM 261515) with an unfavorable (fatal) outcome caused by a mutation in type 4 17ß-hydroxysteroid dehydrogenase (HSD17B4) with a nucleotide replacement of chr5:118788316G>A in the homozygous state is presented. (D-bifunctional protein deficiency or 17-beta-hydroxysteroid dehydrogenase IV deficiency). Bifunctional protein deficiency is an autosomal recessive birth defect of peroxisomal fatty acid oxidation. The total incidence of morbidity is one case per 50,000 newborns. Most peroxisomal disorders manifest in the early neonatal period with an extremely severe course and phenotypic features, which facilitates their diagnosis. This is the difference between them and diseases with a milder and prolonged course, which debuted at different age periods, often had no neonatal or infantile symptoms and were accompanied, in some cases, by satisfactory cognitive functions. The purpose of the report was to highlight the clinical manifestations, variants of the course and complexity of the diagnosis of peroxisomal disorders to a wide range of doctors of different specialization: in the field of perinatology, pediatrics, neurology, genetics, endocrinology.
Publisher
Rostov State Medical University
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference30 articles.
1. van Grunsven EG, van Berkel E, Mooijer PA, Watkins PA, Moser HW, et al. Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basis. Am J Hum Genet. 1999;64(1):99-107. http://doi.org/10.1086/302180
2. Zinovik A.V., Gusina N.B. Peroxisome biogenesis disorders (clinic, diagnosis, treatment). Minsk; 2011. (In Russ.). Accessed on July, 6, 2022. https://www.medcenter.by/documents-downloads/materialy-konferencii/000079_693488__biogeneza_peroksisom.pdf
3. Wanders RJ, Vreken P, Ferdinandusse S, Jansen GA, Waterham HR, et al. Peroxisomal fatty acid alpha- and betaoxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans. 2001;29(Pt 2):250-267. http://doi.org/10.1042/0300-5127:0290250
4. Wanders RJ, Schutgens RB, Barth PG. Peroxisomal disorders: a review. J Neuropathol Exp Neurol. 1995;54(5):726-739. http://doi.org/10.1097/00005072-199509000-00016
5. Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsamis MP, et al. Peroxisomal and mitochondrial defects in the cerebrohepato-renal syndrome. Science. 1973;182(4107):62-64. http://doi.org/10.1126/science.182.4107.62